Prasanna Jagannathan, MD

Assistant Professor, Department of Medicine, UCSF

E-mail Address:


Prasanna Jagannathan

Research Interests:
Naturally acquired cellular immunity to malaria; Immune consequences of antimalarial chemoprevention in Ugandan children; HIV/malaria co-infection


Education and Training:
UCSF, Fellowship, Infectious Diseases, 2009-present

UCSF, Chief Resident, Internal Medicine, San Francisco General Hospital, 2008-2009

UCSF, Internship and Residency, Internal Medicine Residency Program, 2005-2008

Harvard Medical School, M.D., 2005

University of California, Berkeley, B.A., Religious Studies, 1998


Key Publications:

1. Jagannathan P, Muhindo MK, Kakuru A, Arinaitwe E, Greenhouse B, Tappero J, Rosenthal PJ, Kaharuza F, Kamya MR, Dorsey G. Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda. Malar J. 2012 Dec 28; 11(1):435.

2. Shubov A, Jagannathan P, Chin-Hong PV. Pantoea agglomerans pneumonia in a heart-lung transplant recipient: case report and a review of an emerging pathogen in immunocompromised hosts. Transpl Infect Dis. 2011 Oct; 13(5):536-9.

3. Jagannathan P, Davis E, Jacobson M, Huang L. Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series. AIDS. 2009 Aug 24; 23(13):1794-6.

4. Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT, Connors M, Migueles SA. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J Virol. 2009 Mar; 83(6):2728-42.

5. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J. 2008; 7:106.

6. Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J. 2008; 7:107.

7. Jagannathan P, Landovitz RJ, Roland, M. Future HIV Therapy. Post-Exposure Prophylaxis after Sexual Exposure to Human Immunodeficiency Virus. 2007; 1(1):35-47.

8. Smith Fawzi MC, Jagannathan P, Cabral J, Banares R, Salazar J, Farmer P, Behforouz H. Limitations in knowledge of HIV transmission among HIV-positive patients accessing case management services in a resource-poor setting. AIDS Care. 2006 Oct; 18(7):764-71.